These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9616911)

  • 41. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Von Willebrand disease: from diagnosis to treatment].
    Fressinaud E; Meyer D
    Rev Prat; 2005 Dec; 55(20):2209-18. PubMed ID: 16519045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biology of von Willebrand factor].
    Girma JP
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S143-8. PubMed ID: 17373215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of molecular genetics in diagnosing von Willebrand disease.
    James P; Lillicrap D
    Semin Thromb Hemost; 2008 Sep; 34(6):502-8. PubMed ID: 19085649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network.
    Keeney S; Bowen D; Cumming A; Enayat S; Goodeve A; Hill M;
    Haemophilia; 2008 Sep; 14(5):1099-111. PubMed ID: 18637846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology.
    Eikenboom JC
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):365-79. PubMed ID: 11686105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
    Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
    Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of von Willebrand factor in platelet thrombus formation.
    Ruggeri ZM
    Ann Med; 2000 Dec; 32 Suppl 1():2-9. PubMed ID: 11209976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease.
    De Vleeschauwer A; Devreese K
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):353-8. PubMed ID: 16788311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
    Nichols WL; Hultin MB; James AH; Manco-Johnson MJ; Montgomery RR; Ortel TL; Rick ME; Sadler JE; Weinstein M; Yawn BP
    Haemophilia; 2008 Mar; 14(2):171-232. PubMed ID: 18315614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. von Willebrand factor and the endothelium in vascular disease.
    Blann A
    Br J Biomed Sci; 1993 Jun; 50(2):125-34. PubMed ID: 8219918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of endothelium in thrombosis and hemostasis.
    Wu KK; Thiagarajan P
    Annu Rev Med; 1996; 47():315-31. PubMed ID: 8712785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acquired abnormalities of von Willebrand factor: facts to consider in patients with unexpected bleeding.
    Ruggeri ZM
    J Lab Clin Med; 1993 Mar; 121(3):377-9. PubMed ID: 8445284
    [No Abstract]   [Full Text] [Related]  

  • 59. Pathophysiology of platelet-aggregating von Willebrand factor: applications of the venom coagglutinin vWF assay.
    Brinkhous KM; Read MS; Reddick RL; Griggs TR
    Ann N Y Acad Sci; 1981; 370():191-204. PubMed ID: 7023318
    [No Abstract]   [Full Text] [Related]  

  • 60. [Von Willebrand disease].
    Calmette L; Clauser S
    Rev Med Interne; 2018 Dec; 39(12):918-924. PubMed ID: 30279008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.